Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 131

1.

The genetic toxicology of acridines.

Ferguson LR, Denny WA.

Mutat Res. 1991 Sep;258(2):123-60. Review.

PMID:
1881402
2.

Genotoxicity of non-covalent interactions: DNA intercalators.

Ferguson LR, Denny WA.

Mutat Res. 2007 Oct 1;623(1-2):14-23. Epub 2007 Apr 6. Review.

PMID:
17498749
3.

Genetic toxicology of tricyclic carboxamides, a new class of DNA binding antitumour agent.

Ferguson LR, Hill CM, Baguley BC.

Eur J Cancer. 1990;26(6):709-14.

PMID:
2144158
5.

Frameshift mutations induced by four isomeric nitroacridines and their des-nitro counterpart in the lacZ reversion assay in Escherichia coli.

Hoffmann GR, Yin CC, Terry CE, Ferguson LR, Denny WA.

Environ Mol Mutagen. 2006 Mar;47(2):82-94.

PMID:
16180206
6.

DNA-damaging activity and mutagenicity of 16 newly synthesized thiazolo[5,4-a]acridine derivatives with high photo-inducible cytotoxicity.

Di Giorgio C, Nikoyan A, Decome L, Botta C, Robin M, Reboul JP, Sabatier AS, Matta A, De MĂ©o M.

Mutat Res. 2008 Feb 29;650(2):104-14. Epub 2007 Nov 19.

PMID:
18160333
7.
9.

Photo-enhancement of the mutagenicity of 9-anilinoacridine derivatives related to the antitumour agent amsacrine.

Iwamoto Y, Ferguson LR, Pearson A, Baguley BC.

Mutat Res. 1992 Jul;268(1):35-41.

PMID:
1378184
10.
11.

Frameshift mutagenesis by acridines and other reversibly-binding DNA ligands.

Ferguson LR, Denny WA.

Mutagenesis. 1990 Nov;5(6):529-40. Review. No abstract available.

PMID:
2263212
12.

Interest of acridine derivatives in the anticancer chemotherapy.

Demeunynck M, Charmantray F, Martelli A.

Curr Pharm Des. 2001 Nov;7(17):1703-24. Review.

PMID:
11562307
13.

Enhancement of the recombinagenic and mutagenic activities of bleomycin in yeast by intercalation of acridine compounds into DNA.

Hoffmann GR, Ronan MV, Sylvia KE, Tartaglione JP.

Mutagenesis. 2009 Jul;24(4):317-29. doi: 10.1093/mutage/gep012. Epub 2009 Apr 30.

PMID:
19406902
14.

4-Hydroxymethyl-3-aminoacridine derivatives as a new family of anticancer agents.

Charmantray F, Demeunynck M, Carrez D, Croisy A, Lansiaux A, Bailly C, Colson P.

J Med Chem. 2003 Mar 13;46(6):967-77.

PMID:
12620073
15.

Mutagenic activity of some 9-aminoalkyl acridine derivatives on S. typhimurium.

Kalinowska E, Chorazy M.

Mutat Res. 1980 May;78(1):7-15.

PMID:
6991931
16.

Mutagenicity of acridines in a reversion assay based on tetracycline resistance in plasmid pBR322 in Escherichia coli.

Hoffman GR, DeschĂȘnes SM, Manyin T, Fuchs RP.

Mutat Res. 1996 Mar 26;351(1):33-43.

PMID:
8602172
17.

Frameshift mutagenesis of lambda prophage by 9-aminoacridine, proflavin and ICR-191.

Skopek TR, Hutchinson F.

Mol Gen Genet. 1984;195(3):418-23.

PMID:
6236349
18.

Potent antitumor 9-anilinoacridines and acridines bearing an alkylating N-mustard residue on the acridine chromophore: synthesis and biological activity.

Su TL, Lin YW, Chou TC, Zhang X, Bacherikov VA, Chen CH, Liu LF, Tsai TJ.

J Med Chem. 2006 Jun 15;49(12):3710-8.

PMID:
16759114
20.

Genetic effects of dimethyl sulfate, diethyl sulfate, and related compounds.

Hoffmann GR.

Mutat Res. 1980 Jan;75(1):63-129. Review.

PMID:
6767183

Supplemental Content

Support Center